Data leak kickstarts ESMO, BMS reports autoimmune CAR T death, pharma M&A outpaces 2025
From BioSpace · · 23 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Merck stole the show at the European Society for Medical Oncology (ESMO) annual conference, with new data on its Moderna-partnered personalized cancer vaccine leaking prior to the presentation and antibody-drug conjugate sac-TMT making a splash in endometrial cancer; Bristol Myers Squibb revealed the death of a patient with multiple sclerosis in an early-stage trial of zola-cel; and pharma is on track to easily surpass last year’s deal count.